ANI Pharmaceuticals | ANIP - أصول متداولة





أصول متداولة تغيير تاريخ
AbbVie USD 33.53B 4.47B 2026-03
ANI Pharmaceuticals USD 747.08M 6.03M 2026-03
Aurora Cannabis CAD 397.45M 48.38M 2026-03
Canopy Growth CAD 529.47M 4.8M 2026-03
Eli Lilly USD 54.84B 794M 2026-03
Emergent BioSolutions USD 679.5M 41.3M 2023-12
Heron Therapeutics USD 228.98M 9.08M 2026-03
Hikma Pharmaceutical USD 2.64B 86M 2025-12
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Nektar Therapeutics USD 266.27M 15.09M 2025-12
Novartis USD 26.61B 3.85B 2026-03
Omeros USD 69.65M 26.53M 2025-06
Perrigo USD 2.71B 85M 2026-03
Sun Pharmaceuticals INR 638.6B 37.24B 2026-03
Teva Pharmaceutical Industries USD 13.71B 236M 2026-03